T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients

This study has been completed.
Sponsor:
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00520559
First received: August 23, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

The purpose of this study is to provide accurate prognostic data linking cardiac complications to myocardial T2* values (A measure of iron levels in the heart using MRI)in patients predisposed to heart iron overload.


Condition
Thalassemia

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Incidence of Cardiac Complications in Patients With Cardiac Siderosis During 1 Year Follow−up and the Normal T2* Ranges in LVF, MI and Normal Population.

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Enrollment: 665
Study Start Date: January 2007
Study Completion Date: August 2007
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Thalassaemia Major
  • Patient must have had a cardiac MRI scan between 1999 and 2006

Exclusion Criteria:

  • Other structural heart disease such as valvular abnormalities, MI, congenital heart disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00520559

Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Dudley Pennell, MA, MD Imperial College London
  More Information

No publications provided by Imperial College London

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00520559     History of Changes
Other Study ID Numbers: 07/MRE04/32
Study First Received: August 23, 2007
Last Updated: August 23, 2007
Health Authority: United Kingdom: National Health Service
United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Thalassemia
Anemia, Hemolytic, Congenital
Anemia, Hemolytic
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on April 23, 2014